borderline resectable | sciencenewsnet.in

Breaking News

Hackensack Meridian Pascack Valley Medical Center Earns An ‘A’ Hospital Safety Grade from The Leapfrog Group

Keck Hospital of USC earns an ‘A’ Hospital Safety Grade from The Leapfrog Group

Hackensack Meridian Mountainside Medical Center Nurse Wins Research Award at ACC Quality Summit

Breakthrough Idea for CCU Technology Commercialization from ‘Carbon Cycle of the Earth’

Launch of nationwide map viewer and database aids wildfire planning and understanding of treatment effects

Scientists Gain New Insights into How Mass Is Distributed in Hadrons

MSU expert: What the history of lame-duck presidents can tell us about President Biden’s final actions

Helping Soldiers Serve on a Full Stomach

UNC’s Graduate School Waives Application Fee for Current Students and Alumni

Addressing Food Insecurity on Campus with Expanded Resources

15 Nov, 2024

New Study in JNCCN Suggests Way to Predict Outcomes with High Accuracy Prior to Surgery for Pancreatic Cancer Patients

September 8, 2022 sarah JonasResearch Results

New research in the September 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds the use of positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) tracer adds significant prognostic benefit in objectively assessing neoadjuvant chemotherapy response in borderline resectable/locally advanced pancreatic cancer patients prior to surgery.